만성 C형간염 환자에게 페그인터페론과 리바비린 병합치료 중 피부에 발생한 혈관염 1예A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin
- Other Titles
- A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin
- Authors
- 김연호; 한우식; 이순재; 오성남; 최도원; 변관수; 연종은
- Issue Date
- Sep-2007
- Publisher
- Korean Association for the Study of the Liver
- Keywords
- Hepatitis C, chronic; Peginterferon alfa-2a; Vasculitis; Skin; 페그인터페론; 혈관염; 만성 C형간염
- Citation
- The Korean Journal of Hepatology, v.13, no.3, pp 419 - 422
- Pages
- 4
- Indexed
- KCI
- Journal Title
- The Korean Journal of Hepatology
- Volume
- 13
- Number
- 3
- Start Page
- 419
- End Page
- 422
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/18312
- DOI
- 10.3350/kjhep.2007.13.3.419
- ISSN
- 1226-0479
- Abstract
- 본 사례와 같이 만성 C형간염 환자에서 PEG- IFN 치료 중 발생한 혈관염은 임상적으로 해결하기 어려운 문제가 될 수 있다. 그러므로 향후 PEG- IFN 치료 중 발생한 부작용들을 분석하고, 부작용의 발생과 관련된 병리 요인을 분석할 필요가 있다.
There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.